Pregnancy-Associated Plasma Protein-A Increases Osteoblast Proliferation in Vitro and Bone Formation in Vivo

Abstract

Pregnancy-associated plasma protein (PAPP)-A, a protease for IGF binding protein (IGFBP)-2, -4, and -5, may enhance IGF action by increasing its bioavailability. Here we have determined the role and mechanism of action of PAPP-A in the regulation of osteoblast proliferation in vitro and bone metabolism in vivo. Recombinant PAPP-A (100 ng/ml) significantly increased osteoblast proliferation and free IGF-I concentration. These effects were abolished by noncleavable IGFBP-4, suggesting that PAPP-A promotes osteoblast proliferation by increasing IGF bioavailability. To determine whether PAPP-A exerts an anabolic effect on bone in vivo, we developed transgenic mice that overexpress PAPP-A in osteoblasts using the 2.3-kb rat type I collagen promoter. Consistent with the increase in IGFBP-4 proteolysis, free IGF-I concentration was significantly increased in the conditioned medium of cultured osteoblasts derived from transgenic mice compared with the wild-type littermates. Calvarial bone thickness, bone marrow cavity, and skull bone mineral density were significantly increased in transgenic mice. Bone size-related parameters in femur and tibia such as total bone area and periosteal circumference as determined by peripheral quantitated computed tomography and histological analysis were significantly increased in transgenic mice. Bone formation rate and osteoid surface were increased by more than 2-fold, whereas bone resorbing surface was unaffected. These anabolic effects were sustained with aging. These findings provide strong evidence that PAPP-A acts as a potent anabolic factor in the regulation of bone formation. Thus, enhancing IGF bioavailability by PAPP-A can be a powerful strategy in the treatment of certain metabolic diseases such as osteoporosis.

Ephrin B1 Regulates Bone Marrow Stromal Cell Differentiation and Bone Formation by Influencing TAZ Transactivation via Complex Formation with NHERF1

“…The sections were stained for tartrate-resistant acid phosphatase (TRAP), and the TRAP covered surface was measured. All bone histomorphometric parameters were measured as previously described (2,42). Mineral apposition rate (MAR) and the bone formation rate (BFR)/bone surface (BS) ratio were calculated as described previously (41).…”

IGFBP-2 - taking the lead in growth, metabolism and cancer

“…Although formation of the IGFBP-2/IGF-I or -II complex might show an acquired resistance to proteolysis in some cases, a major function of IGFBP proteases is to cleave IGFBP and release IGFs from the IGFBP/IGF complex, an event likely to enhance local IGF action (Gerard et al 2004;Qin et al 2006). This has been exhaustively described in cancer and cancer cell models where proteolysis of IGFBP-2 might be regarded as an important post-translational event contributing to increased tumour aggressiveness.…”

Disruption of claudin-18 diminishes ovariectomy-induced bone loss in mice

“…Two middle longitudinal sections per animal were stained and counted. The trabecular surface and the TRAP-labeled trabecular surface were measured in a blind fashion with the computer software OsteoMeasure (Osteometric, Decatur, GA) (31).…”